Congenital Cytomegalovirus and Hearing Loss: The State of the Art
Journal of Clinical Medicine · 03.07.2023 · 12 (13) · 4465
DOI: 10.3390/jcm12134465 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 03.07.2023. Verfasst von Mirko Aldè und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In developed countries, congenital cytomegalovirus (cCMV) infection is the most common congenital viral infection, representing the leading non-genetic cause of sensorineural hearing loss (HL). Diagnosis of cCMV infection can be performed by detection of CMV DNA in urine or saliva within 2–3 weeks after birth, or later in dried blood samples on the Guthrie card. Currently, there are many controversies regarding the preventive, diagnostic, and therapeutic approaches to cCMV infection. HL secondary to cCMV is highly variable in onset, side, degree, audiometric configuration, and threshold changes over time. Therefore, it is of paramount importance to perform a long and thorough audiological follow-up in children with cCMV infection to ensure early identification and prompt treatment of progressive and/or late-onset HL. Early cochlear implantation appears to be a valid solution not only for children with bilateral profound HL, but also for those with single-sided deafness, improving localization ability and understanding speech in noisy environments. Moreover, the decision to apply a unilateral cochlear implant in children with cCMV is strengthened by the non-negligible possibility of hearing deterioration of the contralateral ear over time.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.
- Audiology Unit, Department of Specialist Surgical Sciences, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
- Department of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy.
- Otolaryngology Unit, Department of Specialist Surgical Sciences, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
ORCID-Profile: Mirko Aldè, Laura Pellegrinelli, Elena Pariani, Fabrizio Pregliasco, Federica Di Berardino, Umberto Ambrosetti
Zitieren
APA
Aldè, M., Binda, S., Primache, V., Pellegrinelli, L., Pariani, E., Pregliasco, F., Di Berardino, F., Cantarella, G., & Ambrosetti, U. (2023). Congenital Cytomegalovirus and Hearing Loss: The State of the Art. Journal of Clinical Medicine, 12(13), 4465. https://doi.org/10.3390/jcm12134465
Vancouver
Aldè M, Binda S, Primache V, Pellegrinelli L, Pariani E, Pregliasco F, et al. Congenital Cytomegalovirus and Hearing Loss: The State of the Art. Journal of Clinical Medicine. 2023;12(13):4465. doi:10.3390/jcm12134465
BibTeX
@article{Ald2023,
author = {Aldè, Mirko and Binda, Sandro and Primache, Valeria and Pellegrinelli, Laura and Pariani, Elena and Pregliasco, Fabrizio and Di Berardino, Federica and Cantarella, Giovanna and Ambrosetti, Umberto},
title = {Congenital Cytomegalovirus and Hearing Loss: The State of the Art},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {13},
pages = {4465},
doi = {10.3390/jcm12134465}
}
EUVIMED